Speaker Profile
Ph.D., Professor and Bioinformatics Core Director, Buck Inst.
Biography
Dr. David Furman is an academic entrepreneur committed to addressing societal and scientific challenges within the human exposome, systems medicine, translational immunology, preventative healthcare, aging biology, and precision longevity. As the Director of the Stanford 1000 Immunomes Project (Stanford University) and Professor and Director of the Bioinformatics and Data Science Core (Buck Institute for Research on Aging), Dr. Furman leads research leveraging multi-scale biology ('omics') platforms and advanced AI/ML methodologies in human cohorts. With over 15 years of specialization in exposomic mechanisms leading to age-related chronic inflammation, his multi-domain expertise includes brain aging, cardiovascular health, metabolic disease and functional aging (decline in intrinsic capacity). Dr. Furman has published over 65 scientific articles in top-tier journals such as Cell, Nature Medicine, PNAS, The Lancet, and others, has collaborated with NASA and SpaceX, and is the inventor of over 20 patents.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Nir Barzilai, Albert Einstein & Mike Snyder, Stanford
PMWC Award Ceremony
• Alexander (Zan) Fleming, Hevolution Foundation (Pioneer)
• Daniel Drucker, Sinai Health (Pioneer)
• Andrea Maier, NUS Yong Loo Lin School of Medicine (Luminary)
Featured Speakers
• Nir Barzilai, Albert Einstein
• Mike Snyder, Stanford
• Andrea Maier, NUS Yong Loo Lin School of Medicine
• Sara Espinoza, Cedars-Sinai
• Brian Kennedy, Buck Institute
• John Newman, Buck Institute / UCSF
• Marco Quarta, Rubedo Life Sciences
• Maria Dermit, Novo Nordisk
• Alan Shuldiner, Regeneron
• David Furman, Stanford
• Steve Horvath, UCLA
• Daniel Belsky, Columbia
• Ahmed Metwally, Google
• Lee Hood, Phenome Health / ISB
• George Slavich, UCLA
Targeting Aging Biology
What is actually druggable today, and what remains wishful thinking.
From Metabolism to Longevity: GLP-1 and Beyond
Incretins reshaping cardiometabolic prevention and healthy aging.
Which Aging Measures Matter?
Biological-age measures and biomarkers that can change clinical decisions.
Wearables & Digital Biomarkers at Scale
Continuous phenotyping and longitudinal signals in real-world aging.
Clinical Translation
Trials, endpoints, regulation, and the hard road to credible longevity medicine.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
